Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What about new licenses?
Why should I care whether or not we sign anyone else in the current quarter? Revenues have not meant didly for pps in past.  Some might use low revs to take pps lower, but I doubt it is going to push it upwards.  Anyway, the cost of a license will be much more later, so what incentive is there to take less now? What is important is to win on all the other fronts at this juncture.  Until then we just need sufficint $ to keep operations going, which I believe is the case.  All IMHO Opty 
Share
New Message
Please login to post a reply